Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma Supritha G. SwamyVivek H. KameshwarAnupam Bishayee Review Article 11 August 2016 Pages: 1 - 10
The Unexpected Roles of Aurora A Kinase in Gliobastoma Recurrences Estelle WillemsArnaud LombardBernard Rogister Review Article 29 August 2016 Pages: 11 - 18
Resistance to Targeted Therapies in Renal Cancer: The Importance of Changing the Mechanism of Action I. DuranJ. LambeaO. Casanovas Review Article 15 November 2016 Pages: 19 - 35
New Biomarkers for Selecting the Best Therapy Regimens in Metastatic Castration-Resistant Prostate Cancer Isabel HeideggerAxel HeidenreichDavid Pfister Review Article 27 October 2016 Pages: 37 - 45
mTOR Inhibitors in Castration-Resistant Prostate Cancer: A Systematic Review Cara M. StatzSara E. PattersonSusan M. Mockus Systematic Review 09 August 2016 Pages: 47 - 59
Impact of Diabetes on Outcomes of Sorafenib Therapy for Hepatocellular Carcinoma Giovan Giuseppe Di CostanzoRaffaella TortoraNicola Caporaso Original Research Article 09 August 2016 Pages: 61 - 67
Effect of Targeting Clusterin Using OGX-011 on Antitumor Activity of Temsirolimus in a Human Renal Cell Carcinoma Model Masatomo NishikawaHideaki MiyakeMasato Fujisawa Original Research Article 15 August 2016 Pages: 69 - 79
Response to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma with the Rare Epidermal Growth Factor Receptor Mutation S768I: a Retrospective Analysis and Literature Review Xiaoli ZhuQianming BaiXiaoyan Zhou Original Research Article 18 August 2016 Pages: 81 - 88
Regorafenib in the Real-Life Clinical Practice: Data from the Czech Registry Katerina KopeckovaTomas BuchlerJana Prausova Original Research Article 14 September 2016 Pages: 89 - 95
Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer Jean-Luc Van LaethemHanno RiessBarrett H. Childs Original Research Article 14 December 2016 Pages: 97 - 109
Adjusting Overall Survival Estimates after Treatment Switching: a Case Study in Metastatic Castration-Resistant Prostate Cancer Konstantina SkaltsaCristina IvanescuNicholas R. Latimer Original Research Article Open access 15 December 2016 Pages: 111 - 121
Erratum to: Aflibercept, a New Way to Target Angiogenesis in the Second Line Treatment of Metastatic Colorectal Cancer (mCRC) Mario ScartozziLoic VincentStefano Cascinu Erratum 20 December 2016 Pages: 123 - 123